Search
SOLACI Congress
HomeFile

File

View Category
Coronary disease

Primary vs Secondary Retrograde Approach in CTO: Differences

Successful chronic total occlusion procedures are on the rise, especially in high volume centers, seeing as they...
solaci -
Learn More
Structural heart disease

Is the Cause of Mitral Regurgitation Relevant for MitraClip?

Mitral regurgitation (MR) is the most common valvulopathy: it is present in (at least) 7.5% of patients...
solaci -
Learn More
Antithrombotic Anticoagulants

Apixaban and Valve Thrombosis after TAVR

TAVR has been associated with early valve thrombosis, characterized by thrombus formation in the prosthetic valve with...
solaci -
Learn More
Acute coronary syndromes

Mortality and Bleeding in Access Site Choice: Systematic Review

In 1992, Kiemeneij performed the first transradial coronary procedure, following Campeau's description of that access in 1989....
solaci -
Learn More
Structural heart disease

Should We Treat Stroke Percutaneously in TAVR?

Since its inception, transcatheter aortic valve replacement (TAVR) has improved greatly. However, there still are five big...
solaci -
Learn More
Structural heart disease

Can We Discharge TAVR Patients the Same Day?

For over a decade, TAVR has been showing great benefits, but conduction abnormalities such as RBBB and...
solaci -
Learn More
Acute coronary syndromes

Heparin Pretreatment in STEACS Treatment: A New Old Ally?

The treatment of ST-segment elevation acute coronary syndromes (STEACS) is undoubtedly reperfusion therapy with primary percutaneous coronary...
solaci -
Learn More
Acute coronary syndromes

RIPCORD 2 Study: Routine Assessment Using Pressure Wires in Acute Coronary Syndrome

The inclusion of fractional flow reserve (FFR) has changed how coronary interventions are treated. Current guidelines endorse...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy